Common Stock, $0.001 par value
- Symbol
- SNES
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 2.02, 9.01 · 8-K
SenesTech, Inc.
SNESNASDAQEQUITYCurrent
Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On November 10, 2026, we announced our financial results for the third quarter ended September 30, 2026. A copy of our press release announcing these financial results and certain other information is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.…
Press release in this filing
SenesTech Reports Record Q3 2026 Revenue with 59% Year-Over-Year Growth →Company context
SenesTech is committed to creating healthier environments by managing animal pest populations through birth control. The company’s groundbreaking products, including Evolve rodent birth control, integrate seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech’s mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are effective and sustainable.
Current securities
Historical securities (1)
Recent company filings
- 4 filingOct 30, 2026
- SCHEDULE 13D/A - filed by GLENBROOK CAPITAL MANAGEMENT regarding SenesTech, Inc.Oct 30, 2026
- 4 filingOct 22, 2026
- SCHEDULE 13D/A - filed by GLENBROOK CAPITAL MANAGEMENT regarding SenesTech, Inc.Oct 22, 2026
- Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Regulation FD DisclosureOct 22, 2026
Registered securities in this filing
SenesTech, Inc. · 8-K · Filed 2026-11-10
Disclosure sections
Item 2.02Item 2.02 - Results of Operations
Item 2.02.
Results of Operations and Financial Condition.
On November 10, 2026, we announced our financial results for the third quarter ended September 30, 2026. A copy of our press release announcing these financial results and certain other information is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
The information in this Item 2.02 (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
We do not have, and expressly disclaim, any obligation to release publicly any updates or any changes in our expectations or any changes in events, conditions, or circumstances on which any forward-looking statement regarding the foregoing subject matter is based.